PRESS RELEASE: IVI’s Updated RA Model Examines New Treatment Options, Treatment Effects and Cost Estimates

IVI has just released the latest update to the organization’s Rheumatoid Arthritis (RA) Value Assessment Model. The updated model now incorporates additional treatment options (triple therapy, Janus Kinase (JAK) inhibitors, sarilumab, and biosimilars), updated treatment effect estimates based on additional randomized controlled trial (RCT) evidence, and updated cost estimates. The model is also designed to […]

PRESS RELEASE: Dr. Patricia Deverka Appointed as IVI’s First Chief Science Officer

IVI is thrilled to announce Pat Deverka, MD has joined our organization as our first Chief Science Officer. Dr. Deverka. Dr. Deverka brings to IVI more than three decades of experience in health economic research, public policy, patient engagement and program measurement across several academic, corporate and non-profit institutions. Read the full press release here […]

PRESS RELEASE: IVI Research Brief Examines Value Assessment in the Age of COVID

Researchers Highlight Important Advancements in Understanding Value Emerging from the Pandemic Alexandria, VA — November 10, 2020 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today released its latest Value Blueprints research brief recommending key areas for adapting […]

PRESS RELEASE: IVI Research Brief: Open-Source Modeling Builds Trust, Validity, and Rapid-Cycle Learning in Value Assessment

Alexandria, VA — November 23, 2020 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today released its latest Value Blueprints research brief describing the benefits and challenges of employing open-source modeling in value assessment. In open-source models, the […]

PRESS RELEASE: IVI Appoints Dr. Richard Chapman as Chief Science Officer

Alexandria, VA — January 26, 2021 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced that Rick Chapman, PhD, will be its next Chief Science Officer. Chapman, who is currently Director of Health Economics at the Institute […]